The global herpes zoster therapeutics market is experiencing a period of substantial growth, driven by factors such as an aging population and growing prevalence of the virus. As per industry analyses, the market is expected to grow at a compounded annual growth rate (CAGR) over the forecast period. Key companies in this market are investing heavil